Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Company Overview More
Tengsheng Boyao Biotechnology Co., Ltd. is a biotechnology company headquartered in China and the United States, mainly engaged in infectious disease therapy research and development business. The company's products are used in infectious diseases (such as hepatitis B virus (HBV), human immunodeficiency virus (HIV), multidrug-resistant (MDR) or extensively drug-resistant (XDR) Gram-negative bacteria infections) and other diseases with significant public health burdens, such as central nervous system (CNS) diseases. The company also develops treatments for COVID-19 and others.
Market: Hong Kong motherboard
Futu Hot List
SymbolLatest price%Chg


Futubull > Quotes > 02137 BRII-B > Company Executives
02137 BRII-B
NamePositionSalaryService DateEducationAgeGenderUpdated
Zhi HONGExecutive director,Chairman of the strategy committee,Chairman of the board,Chairman of the nomination committee,CEO--03/02/2018Doctor58male05/06/2022
罗永庆Executive director,General Manager of Greater China,President--03/30/2021Master--male05/06/2022
Robert Taylor NELSENNon-Executive Director,Member of the strategy committee--06/22/2018Master58male05/06/2022
Martin J Murphy JRChairman of the remuneration committee,Nominating committee member,Independent non-executive director,Member of the audit committee--06/22/2021Doctor79male05/06/2022
Axel BOUCHONNon-Executive Director,Member of the strategy committee--06/22/2021Doctor49male05/06/2022
Grace Hui TANGRemuneration committee member,Independent non-executive director,Chairman of the audit committee--06/22/2021Master62female05/06/2022
徐耀华Nominating committee member,Remuneration committee member,Member of the audit committee,Independent non-executive director--06/22/2021Master72male05/06/2022
严立Chief Medical Officer--04/02/2018Doctor54male05/06/2022
李安康Joint company secretary,CFO,Authorized representative--09/01/2020Doctor44male05/06/2022
Gregg Huber ALTONMember of the strategy committee,Independent non-executive director--06/22/2021Doctor56male05/06/2022
徐连红Senior Vice President (head of Pharmaceutical Chemistry Research and Development)--04/01/2018Doctor56female05/06/2022
Coy STOUTSenior Vice President--09/27/2021Master50male05/06/2022
朱青Senior Vice President (head of Biopharmaceutical Department)--07/16/2020Postdoctoral53female05/06/2022
David MARGOLISVP--10/01/2020Doctor47male05/06/2022
何咏紫Joint company secretary,Authorized representative--04/08/2021Master52female05/06/2022
Karen D. NEUENDORFFChief talent officer--01/27/2022Bachelor46female05/06/2022
Back to the Top